Bryce A. Manso

Dr. Bryce A. Manso

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2019 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
EKEsper G. Kallas
Esper G. Kallas
NGNicole A. Grunenberg
Nicole A. Grunenberg
CYChenchen Yu
Chenchen Yu
BMBryce A. Manso
Bryce A. Manso
GPGiuseppe Pantaleo
Giuseppe Pantaleo
NFNicole Frahm
Nicole Frahm
Antigenic competition in CD4 + T cell responses occurs in HIV vaccine recipients.

5 October 2018 in Leukemia
Verified
Journal Article
Closed access
PDF file
BMBryce A. Manso
Bryce A. Manso
HZHenan Zhang
Henan Zhang
MMMolly G. Mikkelson
Molly G. Mikkelson
KGKimberly A. Gwin
Kimberly A. Gwin
CSCharla R. Secreto
Charla R. Secreto
KMKay L Medina
Kay L Medina

19 April 2024 in Cells
Verified
Journal Article
Open access
PDF file
BMBryce A. Manso
Bryce A. Manso
ABAlessandra Rodriguez y Baena
Alessandra Rodriguez y Baena
CFCamilla Forsberg
Camilla Forsberg
Platelets are the terminal progeny of megakaryocytes, primarily produced in the bone marrow, and play critical roles in blood homeostasis, clotting, and wound healing. Traditionally, megakaryocytes and platelets are thought to arise from multipotent hematopoietic stem cells (HSCs) via multiple discrete progenitor populations with successive, lineage-restricting differentiation steps. However, this view has recently been challenged by studies suggesting that (1) some HSC clones are biased and/or restricted to the platelet lineage, (2) not all platelet generation follows the “canonical” megakaryocytic differentiation path of hematopoiesis, and (3) platelet output is the default program of steady-state hematopoiesis. Here, we specifically investigate the evidence that in vivo lineage tracing studies provide for the route(s) of platelet generation and investigate the involvement of various intermediate progenitor cell populations. We further identify the challenges that need to be overcome that are required to determine the presence, role, and kinetics of these possible alternate pathways.

22 October 2021 in Experimental Hematology
Verified
Journal Article
Closed access
ABAlessandra Rodriguez y Baena
Alessandra Rodriguez y Baena
BMBryce A. Manso
Bryce A. Manso
CFCamilla Forsberg
Camilla Forsberg

1 June 2021 in STAR Protocols
Verified
Journal Article
Open access
BMBryce A. Manso
Bryce A. Manso
KMKay L Medina
Kay L Medina
Transcription factor (TF) expression levels drive developmental programs, including cell fate and function, and their measurement by flow cytometry allows for robust downstream analysis. However, significant batch-to-batch variability between replicative experiments precludes direct comparison of absolute values across experimental conditions. Here, we present a flow cytometry protocol to measure the relative abundance of multiple TFs simultaneously in single cells, allowing for direct comparison across experimental conditions/time points. This protocol uses bone marrow cells but can be adapted for other cell types.

1 February 2024 in EBioMedicine
Verified
Journal Article
Open access
MMMaurine D Miner
Maurine D Miner
ADAllan Decamp
Allan Decamp
NGNicole Grunenberg
Nicole Grunenberg
SRStephen C. De Rosa
Stephen C. De Rosa
AFAndrew Fiore-Gartland
Andrew Fiore-Gartland
ALAnya Luke-Kilolam
Anya Luke-Kilolam
Elicitation of broad immune responses is understood to be required for an efficacious preventative HIV vaccine. This Phase 1 randomized controlled trial evaluated whether administration of vaccine antigens separated at multiple injection sites vs combined, fractional delivery at multiple sites affected T-cell breadth compared to standard, single site vaccination. We randomized 90 participants to receive recombinant adenovirus 5 (rAd5) vector with HIV inserts gag, pol and env via three different strategies. The Standard group received vaccine at a single anatomic site (n = 30) compared to two polytopic (multisite) vaccination groups: Separated (n = 30), where antigens were separately administered to four anatomical sites, and Fractioned (n = 30), where fractions of each vaccine component were combined and administered at four sites. All groups received the same total dose of vaccine. CD8 T-cell response rates and magnitudes were significantly higher in the Fractioned group than Standard for several antigen pools tested. CD4 T-cell response magnitudes to Pol were higher in the Separated than Standard group. T-cell epitope mapping demonstrated greatest breadth in the Fractioned group (median 8.0 vs 2.5 for Standard, Wilcoxon p = 0.03; not significant after multiplicity adjustment for co-primary endpoints). IgG binding antibody response rates to Env were higher in the Standard and Fractioned groups vs Separated group. This study shows that the number of anatomic sites for which a vaccine is delivered and distribution of its antigenic components influences immune responses in humans. National Institute of Allergy and Infectious Diseases, NIH.